Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Allergy Clinical Trials

A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (287) clinical trials

A randomised, double-blind, placebo-controlled trial to evaluate the effect of tralokinumab on vaccine antibody responses in adults with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.  

Phase N/A

Physical exam and assessments of study condition to be provided at no cost by an experienced provider. No insurance necessary. Compensation will be provided at the end of study participation.  

Phase

This study will be testing an investigational drug for peanut allergies  

Phase

 In this study, you will get either MSTT1041A or placebo.  A placebo looks like a drug but has no active ingredient.   About 90 people will take part in this study. MSTT1041A is an experimental drug, which means that is being tested and is not approved for sale in the United ...

Phase

Patients who come to see their Doctor in clinic will be approached to do a 1 time questionnaire before their SOC visit. Questionnaires will be used to see the level of asthma control through a variety of patients who qualify by being diagnosed with Asthma  

Phase N/A

Primary objective is to assess whether dupilumab as adjunct to AR101 compared to placebo improves desensitization at the completion of up-dosing, defined as an increase in the proportion of participants who pass a double-blind placebo-controlled food challenge (DBPCFC) at week 28.

Phase

The primary objective of this trial is to investigate the safety, tolerability and efficacy of BI 655130 in patients with Atopic Dermatitis (AD) following repeated intravenous administrations compared to placebo.

Phase

The primary objective of this trial is to investigate the safety, tolerability and efficacy of BI 655130 in patients with Atopic Dermatitis (AD) following repeated intravenous administrations compared to placebo.  

Phase

The primary objective of the study is to assess whether dupilumab as compared to placebo improves peanut protein tolerability, defined as an increase in the proportion of patients who safely pass a double-blind placebo controlled food challenge (DBPCFC) at week 24. The secondary objectives are: • To determine whether dupilumab ...

Phase